Non Hail-Mary Ventilators have only a 30% survival rate at 1 year mark:
https://www.ncbi.nlm.nih.gov/pubmed/8404197
Incidentally, that's exactly why medical systems to not stockpile ventilators. Under reasonable condition, the number of ventilators closely mirrors the expected number of Hail Mary procedures done at a given time and some spare units.
https://www.thelancet.com/journals/lancet/article/PIIS0140-6...
Plus you need nurses and doctors to intubate the patient and setup and monitor the actual ventilator. The machine itself is a small part of the equation.
I think the focus on ventilators is somewhat misleading. If you need mechanical ventilation, you're a goner anyway, and your bed and healthcare staff could be better used on someone else. The 'lack' of a machine is just a very visible component.
The complications of ventilators and whatever lasting damage is caused by the disease itself; will be killing a significant portion of the recovered population, will it not?
Also put that in context with the fact that Italy reported that the majority of death is with people which have preexisting conditions/other illnesses.
If they do, then less hospitalization, and less ICU / ventilator needs.
If Chloroquine doesn't end up working, basically we need to find something that does, because that is the only feasible way to get us out of this mess. We have shuttered the economy because the healthcare system can't handle so many people needing hospitalization. The only scalable way around that is to find a treatment that significantly lowers the need for hospitalization.
This isn't quite true.
Taiwan, Singapore and S. Korea have not 'shut-down' their economy, and they have tamed the problem.
Massive and widespread testing, assertive isolation and tracking of individuals who test positive can work on some level.
Combined with some other things like maybe keeping 'big gatherings' or 'social gatherings down', requiring people to wear masks on trains, busses, airplanes - we may be able to reasonably suppress Corona without a medical discovery.
I bet you could find five or more recent peer reviewed studies on it working quite well.
You realize most science isn’t double blind, right? I’ll grant you thats it a gold standard for long term drug use but saying “totally unclear it will work” is absurd.
And we still do useful work relying on simple correlations, r values, peer review. We have all that now supporting some of these drugs. In a crisis and last resort that seems like plenty.
Here's a recent review: https://www.sciencedirect.com/science/article/pii/S088394412...
They find hundreds of relevant-sounding papers, registered trials, and guidelines, but almost no data beyond one in vitro study to back it up. That one study is promising--and it'll be great to see what the trials show--but the road from "works in a dish" to "drugs for all" is a long, bumpy one at the best of times.
We need to do this right so that if it works, we know that it works, and if it doesn't, we can make informed decisions to do something else.
That's nice, but most science isn't reproducible at scale. We need to do a drug trial for SARS-CoV-2 because we need to 1)establish efficacy and 2) establish safety for this drug in this disease. There are a significant amount of adverse drug effects in individual infectious diseases. Jarisch–Herxheimer reaction when treating syphilis, epstein-Barr mononucleosis and penicillin; Reye syndrome with Aspirin and influenza. The list is long here. We want the most vetted research possible because even if the chance of death is less than half a percent, half a percent of what seems like is going to be over a million is going to be in the tens of thousands here.
Furthermore, there is a difference between observations of aggregate numbers, like the number of people on ventilators and their survival rate, and small numbers of uncontrolled drug interventions where there are obvious ways for the data to be deceiving. Not all observed data has the same reliability.
No, building a ventilator is like building an engine because you need to go to the store - you're missing so much of the solution to the problem. I've also posted before [1] on why they are a terrible idea to waste time on "designing".
That said, ventilators I believe are already a solved problem for COVID. We have tens of thousands in the strategic stockpile, and production capacity is being ramped up hopefully to meet demand. This is exactly how these stockpiles were intended to work.
1.Montreal offers $200k prize for cheap and easy to build ventilator design - https://news.ycombinator.com/item?id=22637540
2. https://app.handelsblatt.com/unternehmen/industrie/medizinte...
3.https://www.srf.ch/news/schweiz/knappheit-wegen-coronavirus-...
The struggle to ramp up production is a desperate one, and this is one case where IP is killing people - there are several consortia in the UK that are ready to manufacture, but need a certified design they could build.
I think we probably agree that industrial production is the way forward, but the numbers are not particularly comfortable.
There are only 96,596 ICU hospital beds in the United States according to the AHA. As I said, ventilators are already solved to the point that something else is the bottleneck.
I don't think anyone views them quite as starkly as that.
Edit: this development looks very promising for 'sub-intensive' cases -- adapting decathlon masks to provide positive air pressure (to help reinflate lungs) without intubation or leaking contaminated exhaust: https://www.isinnova.it/easy-covid19-eng/. Some emerging theories of pathology suggest that lung function can be increased by reinflating collapsed alveoli with constant pressure: https://emcrit.org/pulmcrit/cpap-covid/